
    
      IDPN is widely used in HD patients without clue of its effectiveness. Study objectives: to
      evaluate IDPN effects on mortality (main objective), hospitalization rates, nutritional
      status, dialysis efficacy, Karnofsky score.

      Patient eligibility: adult patients ≤ 82 y with HD vintage > 6 mo. and 2 of the following
      malnutrition criteria: BMI ≤ 20 kg/m2, BW loss/6 mo. ≥ 10%, serum albumin ≤ 35 g/L,
      prealbumin ≤ 300 mg/L.

      Recruitment: patients in 38 HD units from January 2001 to December 2002 Study protocol.
      Patients are randomized into 2 groups: IDPN group, given IDPN during one year, and control
      group. For ethical reasons, the 2 groups are given oral supplementation during the same
      period.

      Follow-up: two years after start of nutritional therapy. Study end: December 31, 2004. Final
      results will be available in early 2005.
    
  